Le LYSA au 62ème Congrès de l’ASH

Le 62ème Congrès de l'ASH (American Society of Hematology) se déroulera du 05 au 08 décembre 2020 en format virtuel

11 abstracts LYSA ont été sélectionnés !

Découvrez les abstracts :

3 communications orales LYSA :
  • Ro-Chop : final Analysis of the Ro-CHOP Phase III Study (Conducted by LYSA): Romidepsin Plus CHOP in Patients with Peripheral T-Cell Lymphoma | Emmanuel Bachy
  • AHL 2011 : PET-Guided Strategy Improves the Safety of Beacopp-Based Treatment in Advanced Hodgkin Lymphoma: Prolonged Follow-up of the Lysa Ahl 2011 Phase 3 Study | Olivier Casasnovas
  • MRD LyMA : Predictive Power of Early, Sequential MRD Monitoring in Peripheral Blood and Bone Marrow in Patients with Mantle Cell Lymphoma Following Autologous Stem Cell Transplantation with or without Rituximab Maintenance; Final Results from the LyMa-MRD Project, Conducted on Behalf of the Lysa Group | Mary Callanan
8 posters LYSA :